STACEY WILLIAMSON: Open Payments
NPI 1457667891 · TIGARD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 22 payments from 16 companies in 2025. Trend: 2023 $976 · 2024 $1,065 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $54 |
| Medtronic, Inc. | 2 | $52 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $35 |
| BETA BIONICS, INC. | 3 | $25 |
| Novo Nordisk Inc | 1 | $23 |
| Corcept Therapeutics | 1 | $22 |
| Antares Pharma, Inc. | 1 | $19 |
| ARGENX US, INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: JARDIANCE, RECORLEV, MINIMED 780G, iLet Bionic Pancreas, Ozempic, Korlym, INCEPTIV, MOUNJARO.
Industry payments across OR — which companies pay providers there.
